Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 1772 for

Edit search filters
  1. A Study Of The Safety And Effectiveness Of HBI-8000 With Nivolumab To Treat Melanoma, Renal Cell Carcinoma And Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  2. S1602: Different Strains Of BCG With Or Without Vaccine In High Grade Non- Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ

  3. Low Dose Computed Tomography For Lung Cancer Screening

    Rochester, MN

  4. Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, And Filgrastim In Treating Younger Patients With Relapsed Or Refractory Acute Myeloid Leukemia

    Rochester, MN

  5. Cisplatin With Or Without Veliparib In Treating Patients With Recurrent Or Metastatic Triple-Negative And/or BRCA Mutation-Associated Breast Cancer With Or Without Brain Metastases

    Eau Claire, WI, La Crosse, WI, Rochester, MN

  6. A Study To Evaluate CB-839 HCl In Combination With Carfilzomib And Dexamethasone In Treating Patients With Recurrent Or Refractory Multiple Myeloma

    Rochester, MN

  7. Nivolumab And Ipilimumab In Treating Patients With Esophageal And Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

    Rochester, MN

  8. A Study Of Safety, Tolerability, Pharmacokinetic And Pharmacodynamics (PK/PD) In Patients With Hematologic Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. PAC203: A Randomized, Controlled Phase 3 Study Of Pacritinib Versus Physician’s Choice In Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Or Post Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Counts <50,000 _l29_="" />

    Scottsdale/Phoenix, AZ

  10. Aggressive Smoldering Curative Approach Evaluating Novel Therapies And Transplant

    Rochester, MN

.

Mayo Clinic Footer